In addition, when compared with the control group, treatment with DOCA induced the activation of TGF-β and Smad2/3 signaling in 1K/DOCA/salt-treated mice, which was also blocked in APS-treated mice (Figures 3E,F). This evidence concerns the gene SMAD2 and autoimmune polyendocrinopathy.